Physician profile
Mark Bieniarz
NPI 1174776868
$207,469.61
in general payments reported to CMS, 2019-2025
36 companies · $27K in 2025
The $27K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $16K · 2021: $35K · 2022: $26K · 2023: $26K · 2024: $61K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $23K · Honoraria: $22K · Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,968 · Education: $15.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,218.75 |
| Travel and Lodging | $23,144.30 |
| Honoraria | $21,950.00 |
| Food and Beverage | $15,188.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,967.50 |
| Education | $15.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $88,440.69 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $72,339.06 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Amgen INC. | $21,289.42 | 2019-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $6,892.34 | 2020-2024 | Optitorque |
| Merit Medical Systems INC | $4,400.00 | 2021 | |
| Abbott Laboratories | $2,992.78 | 2019-2025 | Triclip, Aveir, Optis |
| Ancora Heart, INC. | $2,646.71 | 2023-2025 | Accucinch |
| Boston Scientific Corporation | $2,079.89 | 2020-2025 | Watchman Access System, Avvigo Guidance System, Watchman |
| Novartis Pharmaceuticals Corporation | $962.79 | 2019-2025 | |
| Philips North America LLC | $955.77 | 2019-2024 | (Bq9) Coronary Ivus, (P88) Igt Devices Fm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $574.54 | 2019-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $475.61 | 2019-2024 | Gore Viabahn Endoprosthesis, Gore Cardioform Septal Occluder |
| Medtronic, INC. | $474.59 | 2021-2025 | Symplicity G3, Selectsecure, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $423.37 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $414.41 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $371.58 | 2019-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $342.65 | 2019-2025 | Farxiga |
| Cardiovascular Systems INC. | $265.76 | 2019-2022 | |
| Livanova USA, INC. | $231.09 | 2022-2023 | Lifesparc |
| Pfizer INC. | $203.82 | 2019-2022 | |
| Baxter Healthcare | $139.29 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Perclot |
| Shockwave Medical, INC | $107.75 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $78.13 | 2021-2024 | Nuvision Ice Catheter, Carto 3 |
| Inspire Medical Systems, INC. | $72.59 | 2023-2025 | Inspire |
| Chiesi USA, INC. | $56.98 | 2022-2025 | Kengreal, Cleviprex |
| Merck Sharp & Dohme LLC | $38.81 | 2023-2025 | Verquvo |
| Tactile Systems Technology INC | $28.53 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.53 | 2019-2021 | |
| Novo Nordisk INC | $28.06 | 2025 | Wegovy |
| Cordis US Corp. | $21.06 | 2023 | Radial 360 |
| Teleflex LLC | $20.76 | 2025 | Guideliner |
| Actelion Pharmaceuticals US, INC. | $19.66 | 2025 | Opsumit |
| Itamar Medical INC | $14.26 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.66 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.41 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$207.40 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bieniarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.